Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Author Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Author Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on RSS
Research ArticleArticle

High-density Lipoprotein Profiling Changes in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors: A Cohort Study

Anna Jamnitski, Johannes H. Levels, Inge A. van den Oever and Michael T. Nurmohamed
The Journal of Rheumatology June 2013, 40 (6) 825-830; DOI: https://doi.org/10.3899/jrheum.121358
Anna Jamnitski
From the Jan van Breemen Research Institute; Academic Medical Centre Amsterdam; and VU University Medical Centre, Amsterdam, The Netherlands.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Johannes H. Levels
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Inge A. van den Oever
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michael T. Nurmohamed
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: m.nurmohamed@reade.nl
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters
PreviousNext
Loading

REFERENCES

  1. 1.↵
    1. Avina-Zubieta JA,
    2. Choi HK,
    3. Sadatsafavi M,
    4. Etminan M,
    5. Esdaile JM,
    6. Lacaille D
    . Risk of cardiovascular mortality in patients with rheumatoid arthritis: A meta-analysis of observational studies. Arthritis Rheum 2008;59:1690–7.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Westlake SL,
    2. Colebatch AN,
    3. Baird J,
    4. Curzen N,
    5. Kiely P,
    6. Quinn M,
    7. et al.
    Tumour necrosis factor antagonists and the risk of cardiovascular disease in patients with rheumatoid arthritis: A systematic literature review. Rheumatology 2011;50:518–31.
    OpenUrlAbstract/FREE Full Text
  3. 3.↵
    1. Van Sijl AM,
    2. Peters MJ,
    3. Knol DL,
    4. de Vet RH,
    5. Sattar N,
    6. Dijkmans BA,
    7. et al.
    The effect of TNF-alpha blocking therapy on lipid levels in rheumatoid arthritis: A meta-analysis. Semin Arthritis Rheum 2011;41:393–400.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Di Angelantonio E,
    2. Sarwar N,
    3. Perry P,
    4. Kaptoge S,
    5. Ray KK,
    6. Thompson A,
    7. et al.
    Major lipids, apolipoproteins, and risk of vascular disease. JAMA 2009;302:1993–2000.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. van Eijk IC,
    2. de Vries MK,
    3. Levels JH,
    4. Peters MJ,
    5. Huizer EE,
    6. Dijkmans BA,
    7. et al.
    Improvement of lipid profile is accompanied by atheroprotective alterations in high-density lipoprotein composition upon tumor necrosis factor blockade: A prospective cohort study in ankylosing spondylitis. Arthritis Rheum 2009;60:1324–30.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Levels JH,
    2. Bleijlevens B,
    3. Rezaee F,
    4. Aerts JM,
    5. Meijers JC
    . SELDI-TOF mass spectrometry of high-density lipoprotein. Proteome Sci 2007;5:15.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Levels JH,
    2. Geurts P,
    3. Karlsson H,
    4. Maree R,
    5. Ljunggren S,
    6. Fornander L,
    7. et al.
    High-density lipoprotein proteome dynamics in human endotoxemia. Proteome Sci 2011;9:34.
    OpenUrlCrossRefPubMed
  8. 8.↵
    1. Watanabe J,
    2. Charles-Schoeman C,
    3. Milao Y,
    4. Elashoff D,
    5. Lee YY,
    6. Katselis G,
    7. et al.
    Proteomic profiling following immunoaffinity capture of HDL: Association of acute phase proteins and complement factors with pro-inflammatory HDL in rheumatoid arthritis. Arthritis Rheum 2012;64:1828–37.
    OpenUrlCrossRefPubMed
  9. 9.↵
    1. Heinecke JW
    . The HDL proteome: A marker — and perhaps mediator — of coronary artery disease. J Lipid Res 2009;50 Suppl:S167–71.
    OpenUrlAbstract/FREE Full Text
  10. 10.↵
    1. Rohrer L,
    2. Hersberger M,
    3. von Eckardstein A
    . High density lipoproteins in the intersection of diabetes mellitus, inflammation and cardiovascular disease. Curr Opin Lipidol 2004;15:269–78.
    OpenUrlCrossRefPubMed
PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 40, Issue 6
1 Jun 2013
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
High-density Lipoprotein Profiling Changes in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors: A Cohort Study
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
High-density Lipoprotein Profiling Changes in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors: A Cohort Study
Anna Jamnitski, Johannes H. Levels, Inge A. van den Oever, Michael T. Nurmohamed
The Journal of Rheumatology Jun 2013, 40 (6) 825-830; DOI: 10.3899/jrheum.121358

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
High-density Lipoprotein Profiling Changes in Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors: A Cohort Study
Anna Jamnitski, Johannes H. Levels, Inge A. van den Oever, Michael T. Nurmohamed
The Journal of Rheumatology Jun 2013, 40 (6) 825-830; DOI: 10.3899/jrheum.121358
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Save to my folders

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgment
    • Appendix 1
    • Appendix 2
    • Footnotes
    • REFERENCES
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters

Keywords

RHEUMATOID ARTHRITIS
HIGH-DENSITY LIPOPROTEINS
LIPID PROFILE
TUMOR NECROSIS FACTOR INHIBITORS
CARDIOVASCULAR RISK

Related Articles

Cited By...

More in this TOC Section

  • Salivary Gland Focus Score Is Associated With Myocardial Fibrosis in Primary Sjögren Syndrome Assessed by a Cardiac Magnetic Resonance Approach
  • Hydroxychloroquine Suppresses Interferon-inducible Genes and B Cell Activating Factor in Patients With Incomplete and New-onset Systemic Lupus Erythematosus
  • The Prevalence of Rheumatoid Arthritis: A Systematic Review of Population-based Studies
Show more Articles

Similar Articles

Keywords

  • rheumatoid arthritis
  • HIGH-DENSITY LIPOPROTEINS
  • LIPID PROFILE
  • TUMOR NECROSIS FACTOR INHIBITORS
  • CARDIOVASCULAR RISK

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2016 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire